- Medical Devices
- Tuesday, 01 Oct 2019
Boston Scientific Announced FDA Approval of ImageReady MRI For Vercise Gevia Deep Brain Stimulation System
Boston Scientific Corporation is a manufacturer, and also engaged in the commercialization of medical devices which are used in wide range of medical specialties. The company offers products for the major seven core businesses such as interventional cardiology, cardiac rhythm management, endoscopy, peripheral interventions, urology and pelvic health, neuromodulation and electrophysiology. The company is operating through three segments namely, MedSurg, Rhythm & Neuro and Cardiovascular. The MedSurg comprises endoscopy and urology and pelvic health segments. The endoscopy business develops and manufactures devices to diagnose and treat a wide range of gastrointestinal (GI) and pulmonary conditions with innovative, less invasive technologies. On the other hand, the urology and pelvic health segment involved in developing and manufacturing devices to treat various urological and pelvic conditions kidney stones, prostate cancer, benign prostatic hyperplasia (BPH), erectile dysfunction, pelvic floor disorders, male incontinence, abnormal uterine bleeding and uterine fibroids & polyps. The Rhythm & Neuro segment covers cardiac rhythm management, electrophysiology and neuromodulation areas. Whereas, the cardiovascular segment involves interventional cardiology and peripheral interventions.
Boston Scientific Corporation received FDA approval for its ImageReady MRI labeling for the Vercise Gevia Deep Brain Stimulation (DBS) System to be used in a full-body magnetic resonance imaging (MRI) environment. Strong international operations with six principal international manufacturing facilities, across Ireland, Costa Rica and Puerto Rico. Product marketing done in 100 countries through its direct sales force, which is actively supporting in 40 countries. The business segments of Boston are focusing towards implementation of new measures to improve its existing position in the market.
Related Industry Updates
Mammography Detectors Market is expected to reach US$ 234.65 million by 2030
Dec 28, 2023
Global $X.XX Billion COVID-19 Medical Sterile Swabs Market to 2027
Jan 04, 2021
Asia Pacific Bovine and Goat Colostrum Market: Industry Overview, Trends and Growth Opportunities Forecasted Till 2027
Dec 08, 2020
Anal Fistula Market : Growth Prospects, Key Vendors, Future Scenario Forecast By 2027
Dec 04, 2020
Electromyography Market Innovative Solutions to Cater to Customer’s Demands and To Expand Their Business by Top Vendors: Deymed Diagnostic, Mayo Clinic, Dräger, Ebneuro, EMS Biomedical, Natus Medical Incorporated
May 07, 2021
R&D will lessen the Excise Tax of medical devices
Jan 16, 2020
Healthcare Mobility Solutions Market: Value Chain, Stakeholder Analysis and Trends
Feb 24, 2021